| |
|
|
|
One of the most
amazing benefits of
Marvlix is its anti-cancer
effect. An increasing number of doctors worldwide recommend Cordyceps as an
alternative, or addition, to chemotherapy, radiation, or other
traditional cancer treatment.
Cordyceps has been used successfully to
inhibit the growth of cancer cells, and to
help dissolve cancerous tumors.
|
|
In addition, clinical studies have proven that
Cordyceps enhances and strengthens the immune system, enabling
the body to manage its immune resources more
efficiently while undergoing the stress of cancer attack.
This secondary effect is extremely important for patients going
through chemotherapy or radiation treatment, strengthening
the body against the toxic side effects of those treatments. It is no
secret that many cancer patients die of opportunistic infections during
chemotherapy rather than from the cancer itself. The use of Marvlix minimizes the risk of complication.
Many clinical studies
of cancer patients have shown positive results. In one study, 50 lung
cancer patients were treated with 6 grams of Cordyceps daily,
in conjunction with chemotherapy. Tumors were reduced in size in 46%
of the patients.
In a trial involving cancer patients with several
different types of tumors, a majority of those treated for two months
with 6 grams of Cordyceps daily, reported improved subjective symptoms.
In approximately 50% of the patients, white blood cell counts remained
high, while tumor size
was significantly reduced.
Read more on benefits
of Marvlix:
Anti-Aging Effects
Alternative
Diabetes Treatment
Liver
Health and High Cholesterol
Heart Health
Kidney Health
Lung Health
Reduction of Drug Toxicity
Ready to order? Go directly to our online
store. Open 24 hours a day, 7 days a week. Money back is
guaranteed.
References
Jia-Shi Zhu,
M.D., Ph.D. and James Rippe, M.D. (2004) Presented at the American
Physiological Society's (APS) annual scientific conference,
Experimental Biology 2003, held April 17-21, 2004, in Washington, D.C.
Shin KH, Lim
SS, Lee S, Lee YS, Jung SH, Cho SY. (2003) Anti-tumour and
immuno-stimulating activities of the fruiting bodies of Paecilomyces
japonica, a new type of Cordyceps spp. Phytother Res. 2003 Aug;
17(7):830-3.
Koh JH, Yu
KW, Suh HJ, Choi YM, Ahn TS. (2002) Activation of macrophages and the
intestinal immune system by an orally administered decoction from
cultured mycelia of Cordyceps sinensis. Biosci Biotechnol Biochem,
2002 Feb; 66(2):407-11.
Smith, Rowen
and Sullivan (2002), Medicinal Mushrooms: Their Therapeutic Properties
and Current Medical Usage with Special Emphasis on Cancer Treatment,
May 2002; 106-141.
Hsu T. H.,
Shiao L. H., Hsiea C., and Chang D. M. 2002. A comparison of the
chemical composition and bioactive ingredients of the Chinese
medicinal mushroom DongChongXiaCao, its counterfeit and mimic, and
fermented mycelium of Cordyceps sinensis. Food Chem, 78:463-469.
Wang, R.,
Xie, J., Ji, P., Li, S., Zhan, H., Xia, J., Sun, H., Lei, L., Yu, J.,
Wang, Y., Holliday, J., Clinical Trial report on Chronic Hepatitis
treatment using Immune-Assist brand mushroom extract mixture in
conjunction with the drug Lamivudine Wasser, S.P., (2002) Medicinal
mushrooms as a source of antitumor and immunomodulating
polysaccharides. Appl Microbiol Biotechnol, 2002; 60:258-274.
Yue-Qin C,
Ning W, Hui Z, Liang-Hu Q. (2002) Differentiation of medicinal
Cordyceps species by rDNA ITS sequence analysis. Planta Med. 2002 Jul;
68(7):635-9.
Creadon, M.
and Dam, J. (1996). " Drink up." Time (August 19): 55. a
biologically active compound from cultures mycelia of Cordyceps and
Isaria species. Phytochemistry, 22:2509-2512.
Gordon, D.
(1993). : The rumored dope on Beijing's Women." Newsweek
September 27): 63. Grey, P. and Barker, R. (1993). Cordyceps or plant
eats animal! The Victorian Naturalist, 110:98-107.
Guan, Y.J.,
Hu, G., Hou, M., Jiang, H., Wang, X., and Zhang, C. (1992). Effect of
Cordyceps sinensis on T- lymphocyte subsets in chronic renal railure.
Chinese Journal of Integrated Medicine, 12:323, 338-339.
Guo, Y. Z.
(1986). [Medicinal chemistry, pharmacology and clinical applications
of fermented mycelia of Cordyceps sinensis and JinShuBao capsule].
Journal of Modern Diagnostics and Therapeutics, 1:60-65.
Guo QC, Zhang
C. (1995) Clinical Observations of Adjunctive Treatment of 20 Diabetic
Patients with JinSHuiBao Capsule. J Administration Traditional Chinese
Medicine 1995; 5(suppl):22.
Bok JW,
Lermer L, Chilton J, Klingeman HG, Towers GH., (1999) Antitumor
sterols from the mycelia of Cordyceps sinensis. Phytochemistry 1999
Aug; 51(7):891-8.
Chamberlain,
M. (1996). Ethnomycological experiences in South West China.
Mycologist, 10 (4):173-176.
Chang, H.M.
and But, P.P.H. (Eds.) (1986). Pharmacology and Applications of
Chinese Materia Medica, 1. Philadelphia, PA: World Scientific, pp.
410-413.
Chen, J.R.,
Yen, J.H., Lin, C.C., Tsai, W.J., Liu, W.J., Tsai, J.J., Lin, S.F.,
and Liu, H.W. (1993). The effects of Chinese herbs on improving
survival and inhibiting anti-ads DNA antibody production in lupus
mice. American Journal of Chinese Medicine, 21:257-262.
Chen K, Li C.
(1993) Recent advances in studies on traditional Chinese anti-aging
Materia Medica. J Tradit Chin Med 1993 Sep; 13(3):223-6.
Chen, S.Z.
and Chu, J.Z. (1996). [NMR an IR studies on the characterization of
cordycepin and 2'deoxyadenosine]. Zhongguo Kangshengsu Zaxhi,
21:9-12.
Hammerschmidt,
D.E. (1980). Szechwan purpura. New England Journal of Medicine,
302:1191-1193.
Holliday, J.,
Cleaver, P., Loomis-Powers, M., and Patel, D., Analysis of Quality and
Techniques for Hybridization of Medicinal Fungus Cordyceps sinensis,
International Journal of Medicinal Mushrooms, Vol. 6, pp. 147-160
(2004).
Huang, Q.,
Li, D., Liang, J., Liao, S., and Liang S., (1991). [Weak polar
chemical components in Cordyceps]. Journal of Chinese Medical
Materials, 14:33-34.
Ikumoto, T.,
Sasaki, S., Namba, H., Toyama, R., Moritoki, H., and Mouri, T. (1991).
[Physiologically active compounds in the extracts from tochukaso and
cultured mycelia of Cordyceps and Isaria]. Yakugaku Zasshi,
111:504-509.
Huang , Y. et
al (1987) Toxicology studies on cultured Cordyceps sinensis strain
B414. Zhongchengyao Yanjiu 10:24-25 From Abstracts of Chinese
Medicine, 2:321.
Chen, Y.Q.,
Wang, N., Qu, L., Li., T., and Zhang, W. (2001). Determination of the
anamorph of Cordyceps sinensis inferred from the analysis of the
ribosomal DNA internal transcribed spacers and 5.85 rDNA. Biochemical
Systematics and Ecology, 29:597-607.
Kadota, S.,
Shima, T., and Kikuchi, T. ( 1986) [Steroidal components of
"I-Tiam-Hong" and Cordyceps sinensis. Separation and
identification by high-performance liquid chromatography]. Yakugaku
Zasshi, 106:1092-1097.
Kiho, T.,
Tabata , H., Ukai, S., and Hara, C., (1986). A minor
protein-containing galactomannan from a sodium carbonate extracted of
Cordyceps sinensis. Corbohydrate Reseach, 156:189-197.
Kiho T, Hui
J, Yamane A, Ukai S. (1993) Hypoglycemic activity and chemical
properties of a polysaccharide from the cultural mycelium of Cordyceps
sinensis. Biol Pharm Bull 1993 Dec; 16(12):1291-3.
Kiho T,
Yamane A, Hui J, Usui S, Ukai S. (2000) Hypoglycemic activity of a
polysaccharide (CS-F30) from the cultural mycelium of Cordyceps
sinensis and its effect on glucose metabolism in mouse liver.
Phytother Res 2000 Dec; 14(8):647-9.
Kuo, Y.C.,
Tsai, W.J., Shiao, M.S., Chen, C.F., and Lin, C.Y. (1996) Cordyceps
sinensis as an immunomodulatary agent. American Journal of Chinese
Medicine, 24:111-125.
Kuo, Y.C.,
Tsai, W.J., Wang , J.Y., Chang, S.C., Lin, C.Y., and Shiao, M.S.
(2001). Regulation of bronchoalveolar lavage fluids cell function by
the immunomodulatory agents from Cordyceps sinensis. Life Sciences,
68:1067-1082.
Hawksworth D.
L., et al. 1995 Ainsworth and Bisbi's Dictionary of the Fungi: 8th ed.
International, University Press and Cambridge, 616 pp.
Hirose K.,
and Yahagi N. 1997. Japan tochukaso, Shock to Disappear of Cancer.
Metamoru shyupan, Tokyo, 175 pp.
Itami H., and
Yahagi N. 1996. Japan tochukaso, Challenge for Terminal Cancer.
Metamoru shyupan, Tokyo, 140pp.
Jiang, JC,
Gao, YF. Summary of treatment of 37 chronic renal disfunction patients
with JinShuiBao. J Administration Traditional Chinese Med 1995;
5(suppl):23-24.
Kiho T., and
Ukai S. 1995. Tochukaso (Semitake and others), Cordyceps species. Food
Rev Int, 11, 231-234.
Kiho T., Hui,
J., Yamane A., and Ukai S. 1993. Hypoglycemic activity and chemical
properties of a polysaccharide from the cultural medium of Cordyceps
sinensis. Bio Pharmacol Bull, 16:1291-1293.
Hiho T.,
Yamane A., Hui J., Usui S., and Ukai S. 1996. Hypoglycemic activity of
a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps
sinensis and its effect on glucose metabolism in mouse liver. Biol
Pharmacol Bull, 19:294-296.
Kobayashi Y.,
and Shimizu D., 1983. Iconography of Vegetable Wasps and Plant Worms.
Hoikusha Tokyo, 208 pp.
Kubo M. 1996
Tochukaso. Its secret and its Power. Hoikusha,, Tokyo, pp. 128, 152.
Li, L.S. and Zheng, F. (1992). Clinical protection of aminoglycoside
neophrotoxiciry by Cordyceps sinensis (CS). Journal of the American
Society of Nephrology, 3:726 (ABSTRACT 24p).
Liu FA, Zheng
X, (1993) Study of Cordyceps sinensis on anti-laryngeal carcinoma. J.
Norman Bethune University Med Sci, 1993; 19(1):57-58.
Liu, C., Xue,
HM., Xu, LM., Zhao, PZ., Zhang, LB., Tang, MG., Treatment of 22
patients with post hepatic cirrhosis with a preparation of fermented
mycelia of Cordyceps sinensis. Shanghai J Chinese Materia Medica,
1986; 6:30-31.
Leung, A.K.,
Gong, F., and Chau, F. (2000). Analysis of the water soluble
constituents of Cordyceps sinensis with heuristic evolving latent
projections. Analytical Letters, 33:3195-3211.
The Merck
Index, 11 Edition, 1989. 2524 Cordycepin. Merk and Co., 395 pp.
Mizuno
T.1997. Development and ultilization of bioactive substances from
medical and edible mushrooms fungi (10) Charga, Sclerotiana of
Fuscopotia oblique (Fr) Aoshima. The Chemical Times, 163:9-15.
Mizuno T.
1998. Immunological Diet for Cancer Serious Disease. Gendaishorin,
Tokyo, 188 pp.
Nakamura K,
Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M., Activation of in-vivo
Kupffer cell function by oral administration of Cordyceps sinensis in
rats. (1999) Jpn J Pharmacol, 1999 Apr;79(4):505-8.
Nakamura K,
Konoha K, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M. (2003)
Combined effects of Cordyceps sinensis and methotrexate on hematogenic
lung metastasis in mice. Receptors Channels, 2003; 9(5):329-34 .
Ohmori T.,
Tamura K., Tsuru S., and Nomoto K., 1986. Antitumor activity of
protein-blood polysaccharide from Cordyceps ophioglossoides in mice.
Jnp J Cancer Res (Gann), 77:1256-1263.
Ohmori T.,
Tamura K., Furuki K., Kawanishi G., Mitsuyama M., Nomoto K., Miyazaki
t, 1989. Isolation of galactosaminoglycan moity (CO-N) from
protein-bound polysaccharide of Cordyceps ophioglossoides and its
effects against murine tumor. Chem Pharmacol Bull, 37:1019-1022.
Parcell AC,
Smith JM, Schulthies SS, Myrer JW, Fellingham G. (2004) Cordyceps
Sinensis (CordyMax Cs-4) supplementation does not improve endurance
exercise performance. Int J Sport Nutr Exerc Metab. 2004 Apr;
14(2):236-42.
Pelleg, A.,
Porter, R.S. (1990) The pharmacology of adenosine. Pharmacotherapy,
1990; 10:157-174.
Shin KH, Lim
SS, Lee SH, Lee YS, Cho SY (2001) Antioxidant and immunostimulating
activities of the fruiting bodies of Paecilomyces japonica, a new type
of Cordyceps sp. Ann N Y Acad Sci. 2001 Apr; 928:261-73.
Shimizu D.
1994. Color Iconography of Vegetable Wasps and Plant Worms.
Seibundoshinksosha, Tokyo, 381 pp.
Suh SO, Noda
H, Blackwell M (2001)Insect symbiosis: derivation of yeast-like
endosymbionts within an entomopathogenic filamentous lineage. Mol Biol
Evol. 2001 Jun; 18(6):995-1000.
Takeuchi N.
1998. Pharmacological effect of Tochukaso and its utilization for
food. Kagaku to Kogyo, 51:1614-161.
Toda, N.,
Okunishi, H., Taniyama, K., Miyazaki, M., (1982) Response to adenine
nucleotides and related compounds of isolated dog cereberal, coronary
and mesenteric arteries. Blood Vessels, 1982; 19:226-236.
Ukai S, Kiho
T, Hara C, Morita M, Goto A, Imaizumi N, Hasegawa Y (1983)
Polysaccharides in fungi: XIII. Antitumor activity of various
polysaccharides isolated from Dictyophora indusiata, Ganoderma
japonicum, Cordyceps cicadae, Auricularia uricula-judae and
Auricularia sp. Chem Pharma Bull (Tokyo), 31:741-744.
Yamanaka K.,
and Inatomi S, 1997. Cultivation of Isaria japonica fruit bodies on
mixed plant/insect media. Food Rev Int, 13:455-460.
Segelken, R.
(2002) Cyclosporin mold's 'sexual state' found in New York forest
Cornell students' discovery could target additional sources of
nature-based pharmaceuticals Cornell University Science News, Sept 16,
1996.
Tai-Hao, H.,
Hui-Chen, L., Biological activity of Cordyceps (Fr.) Link Species
(Ascomycetes) Derived from a Natural Source and from Fermented Mycelia
on Diabetes in STZ-Induced Rats. Inter J of Med Mush, 4:111-125.
Xu, W.Z.,
Wei, J.P., Wang N. Q., Liu T., (1988) Experimental study of the
combined chemotherapy of Zhiling Capsules and Anticancer agents.
Shanghai Zhongyiyao Zazhi 1988; (6):48.
Xu, F., Huang
JB., Jiang, L., Xu, J., Mi, J., (1995) Amelioration of cyclosporin
nephrotoxicity by Cordyceps sinensis in kidney transplanted
recipients. Nephrol Dial Transplant 1995; 10(1):142-143.
Yamada H.,
Kawaguchi N., Ohmori T., Takeshita Y., Teneya S., and Miyazaji t.
1984. Structure and antitumor activity if an alkali-soluble
polysaccharide from Cordyceps ophioglossoides. Carbohydr Res, 125,
107-115.
Yamaguchi N.,
et al, (1990) Augmentation of various immune reactivities of tumor
bearing hosts with an extract of Cordyceps sinensis. Biotherapy,
2:199-205.
Yang, YZ.,
Wang, LS., Deng, HY., Ma, YS., Wu, HS., Short term observation of
treating chronic hepatitis B and post hepatic cirrhosis with
XinGanBao. Res Chinese Materia Medica 1994; 1:19-20.
Yoshida J et
al (1989) Antitumor activity of an extract of Cordyceps sinensis
(Berk.) Sacc. Against murine tumor cell lines Jpn J Exp Med,
59:157-161.
Zhao CS, Yin
WT, Wang JY, Zhang Y, Yu H, Cooper R, Smidt C, Zhu JS. (2002)
Cordyceps Cs-4 improves glucose metabolism and increases insulin
sensitivity in normal rats. J Altern Complement Med. 2002 Aug;
8(4):403-5.
Halpern, G.,
(1999) Cordyceps, Chinas healing mushroom. Avery Publishig 1999: 63-70
Bao, Z.D., Wu, Z.G., and Zheng, F. (1994). [Amelioration of
aminoglycoside nephrotoxicity by Cordyceps Sinensis in old patients].
Chinese Journal of Integrated Medicine, 14:259,271-273.
Berne, R.M.,
1980: The role of Adenosine in the regulation of coronary blood flow.
Circ. Res. 1980; 47:807-813.
Wu T. N.,
Yang K. C., Wang C. M., Lai J. S., Ko K. N., Chang P. Y., and Liou S.
H. 1996. Lead poisoning caused by contaminated Cordyceps, a Chinese
herbal medicine: two case reports. Sci Total Environ, 182, 193-195.
|
|
